Element Capital Management’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-30,569
Closed -$2.86M 19
2023
Q3
$2.86M Sell
30,569
-2,272
-7% -$210K 0.25% 111
2023
Q2
$3M Buy
+32,841
New +$2.69M 0.2% 129
2019
Q2
Sell
-8,062
Closed -$994K 265
2019
Q1
$994K Buy
8,062
+5,796
+256% +$727K 0.03% 371
2018
Q4
$265K Buy
2,266
+179
+9% +$21.1K 0.01% 486
2018
Q3
$261K Buy
+2,087
New +$230K 0.01% 645

Other funds holding AMED

Element Capital Management's AMED Position: Q4 2023 in Review

Element Capital Management sold out of Amedisys (AMED) in Q4 2023, closing a stake of 30,569 shares — an estimated $2.86M sold.

Element Capital Management first reported a position in AMED in Q3 2018 and held it in 5 quarters. The position peaked at $3M in Q2 2023. 287 funds tracked by Wall St. Rank hold AMED as of Q4 2023.

  • Element Capital Management reported no remaining Amedisys position as of Q4 2023 after selling out during the quarter.
  • Element Capital Management sold 30,569 Amedisys shares in Q4 2023, an estimated $2.86M.
  • Element Capital Management first reported a position in Amedisys in Q3 2018 and held it in 5 quarters.
  • Element Capital Management's Amedisys position peaked at $3M in Q2 2023.
  • 287 funds tracked by Wall St. Rank held Amedisys as of Q4 2023.

Based on Element Capital Management's 13F filing for Q4 2023, filed 9 Feb 2024.